A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster ModelJakob Kreye, Harald Prüß, Stefan Hippenstiel et al.|Cell|2020Cited by 387
Age-Dependent Progression of SARS-CoV-2 Infection in Syrian HamstersNikolaus Osterrieder, Jakob Trimpert, Luca D. Bertzbach et al.|Viruses|2020Cited by 243
The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 InfectionJakob Trimpert, Nikolaus Osterrieder, Daria Vladimirova et al.|Cell Reports|2020Cited by 100
SARS‐CoV‐2 infection of Chinese hamsters (<i>Cricetulus griseus</i>) reproduces COVID‐19 pneumonia in a well‐established small animal modelLuca D. Bertzbach, Jakob Trimpert, Daria Vladimirova et al.|Transboundary and Emerging Diseases|2020Cited by 78
Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recodingJakob Trimpert, Dušan Kunec, Kristina Dietert et al.|Cell Reports|2021Cited by 75